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Abstract
Leukocyte adhesion and transmigration are central features governing immune surveillance
and inflammatory reactions in body tissues. Within the liver sinusoids, chemokines initiate
the first crucial step of T-cell migration into the hepatic tissue. We studied molecular mecha-
nisms involved in endothelial chemokine supply during hepatic immune surveillance and
liver inflammation and their impact on the recruitment of CD4+ T cells into the liver. In the
murine model of Concanavalin A-induced T cell-mediated hepatitis, we showed that hepatic
expression of the inflammatory CXC chemokine ligands (CXCL)9 and CXCL10 strongly in-
creased whereas homeostatic CXCL12 significantly decreased. Consistently, CD4+ T cells
expressing the CXC chemokine receptor (CXCR)3 accumulated within the inflamed liver tis-
sue. In histology, CXCL9 was associated with liver sinusoidal endothelial cells (LSEC)
which represent the first contact site for T-cell immigration into the liver. LSEC actively trans-
ferred basolaterally internalized CXCL12, CXCL9 and CXCL10 via clathrin-coated vesicles
to CD4+ T cells leading to enhanced transmigration of CXCR4+ total CD4+ T cells and
CXCR3+ effector/memory CD4+ T cells, respectively in vitro. LSEC-expressed CXCR4 me-
diated CXCL12 transport and blockage of endothelial CXCR4 inhibited CXCL12-dependent
CD4+ T-cell transmigration. In contrast, CXCR3 was not involved in the endothelial transport
of its ligands CXCL9 and CXCL10. The clathrin-specific inhibitor chlorpromazine blocked
endothelial chemokine internalization and CD4+ T-cell transmigration in vitro as well as mi-
gration of CD4+ T cells into the inflamed liver in vivo. Moreover, hepatic accumulation of
CXCR3+ CD4+ T cells during T cell-mediated hepatitis was strongly reduced after adminis-
tration of chlorpromazine. These data demonstrate that LSEC actively provide perivascu-
larly expressed homeostatic and inflammatory chemokines by CXCR4- and clathrin-
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dependent intracellular transport mechanisms thereby contributing to the hepatic recruit-
ment of CD4+ T-cell populations during immune surveillance and liver inflammation.
Introduction
Migration of leukocytes into tissues is central for immune surveillance and pathogen defence
as well as for the pathogenesis of autoimmune diseases. Leukocyte recruitment from the circu-
lation is a tightly regulated multistep process depending on specific interactions between adhe-
sion molecules and chemokine receptors expressed by the leukocytes and their respective
ligands on the vascular endothelial cells [1,2]. The model of transmigration across an endothe-
lium involves several distinct steps. Endothelial selectins mediate initial tethering and rolling of
circulating leukocytes whereas endothelium-bound chemokines trigger subsequent stable ad-
hesion and transendothelial migration [3,4]. Transcytosis, a process by which molecules inter-
nalized at one plasma membrane of a polarized cell are transported via vesicles to the opposite
membrane, is one assumed mechanism how perivascularly expressed chemokines reach the
blood-endothelial interface for presentation [5,6].
Chemokines can be generally classified into inflammatory and homeostatic chemokines.
Constitutively expressed homeostatic chemokines like the CXC chemokine ligand (CXCL)12
are involved in the control of physiological leukocyte recirculation and in immune surveillance.
Inflammatory chemokine expression is induced in inflamed tissues by pro-inflammatory cyto-
kines like interferon (IFN)-γ and consistently controls recruitment of effector cells determining
the composition of inflammatory cell infiltrates and the outcome of local inflammation [7,8].
CXCL9 and CXCL10 belong to the group of inflammatory chemokines binding to the common
CXC chemokine receptor (CXCR)3 [9] and are critical for the recruitment of effector T cells in
various liver diseases [10–13].
Circulating T cells pass the liver via the sinusoids, a network of small capillaries lined by
liver sinusoidal endothelial cells (LSEC). The sinusoidal endothelium is a major route for T-cell
entry into the liver parenchyma from where recruited cells can subsequently migrate to sites of
inflammation [14,15]. T-cell rolling is greatly attenuated in the liver probably due to low levels
of shear stress in hepatic sinusoids. The small luminal diameter of the sinusoids in combination
with the slow hepatic blood flow in itself is sufficient to allow prolonged contact for the first in-
teractions between lymphocytes and LSEC [16,17]. Thus, endothelial chemokine supply may
be particularly important for T-cell recruitment into the liver.
We previously showed that LSEC promote chemokine-dependent CD4+ T-cell transmigra-
tion in vitro [18]. In the present study, we addressed molecular mechanisms involved in LSEC-
mediated chemokine supply in more detail and analyzed their contribution to the hepatic re-
cruitment of CD4+ T cells during immune surveillance and liver inflammation.
Material and Methods
Mice
C57BL/6 mice were obtained from the Charité animal facility (Berlin, Germany) or Charles
River (Wilmington, MA). CXCR3-/- mice [11] were kindly provided by PD Dr. Uta Höpken
(Department of Tumor Genetics and Immunogenetics, Max-Delbrück-Center for Molecular
Medicine, Berlin, Germany). All mouse experiments were conducted according to the German
animal protection laws (Landesamt für Gesundheit und Soziales, Berlin, Germany; G 0022/09,
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G 0336/08, T 0183/07) with approval from the Charité—Universitätsmedizin ethical commit-
tee. All mice received humane care according to the national guidelines.
Cell isolation
To isolate non-parenchymal cells (NPC), livers were perfused in situ with digestion medium
containing collagenase IV (Sigma-Aldrich, Steinheim, Germany) injected into the portal vein,
excised and further incubated in the digestion medium. To eliminate parenchymal cells, the
single-cell suspension was subjected to a one-step density gradient centrifugation with 26%
Nycodenz (Progen Biotechnik, Heidelberg, Germany). LSEC were isolated from NPC by mag-
netic cell sorting using anti-CD146 antibody (ME-9F1; BioLegend, Fell, Germany) as previous-
ly described [19]. LSEC adhered over night and were subsequently washed in order to remove
non-adherent cells resulting in a purity of higher than 99% [20]. For transmigration assays,
CD4+ T cells were isolated from spleen and lymph nodes using anti-CD4 MicroBeads (Milte-
nyi Biotec, Bergisch Gladbach, Germany) to a purity of at least 95%. Untouched CD4+ T cells
used for homing assays were isolated by CD4+ T Cell Isolation Kit (Miltenyi Biotec) according
to the manufacturer’s instruction to a purity of at least 95%.
FACS analysis
NPC were stained with anti-CD4 (RM4-5), anti-CD90.2 (53–2.1), anti-CD69 (H1.2F3; all BD
Biosciences, Heidelberg, Germany) or anti-CXCR3 antibody (CXCR3-173; eBiosciences, San
Diego, CA). For detection of cytokine-expressing cells, NPC were re-stimulated with phorbol
myristate acetate (10 ng/ml) and ionomycin (500 ng/ml) for 4 h with the addition of brefeldin
A (10 μg/ml; all Sigma-Aldrich) after 60 min. Cells were fixed with 2% paraformaldehyde.
After permeabilization using 0.5% saponin, NPC were stained with anti-IFN-γ antibody
(XMG1.2; BD Biosciences). Unspecific binding was blocked with rat immunoglobulin (Dia-
nova, Hamburg, Germany) and anti-CD16/32 antibody (93; BioLegend). LSEC were incubated
with AlexaFluor 647-labeled CXCL10 or CXCL12 (both 10 nM; Almac, Craigavon, UK). LSEC
were treated with chlorpromazine (CPZ; 30 μM), nystatin (10 μM) or filipin (15 μM) for 10
min and AMD3100 (10 μM; all Sigma-Aldrich) for 60 min, washed and further incubated with
the chemokines for 60 min. Data were acquired using a FACS Canto II (BD Biosciences) and
analyzed by the FlowJo software (Tree Star, Ashland, OR).
In vitro activation of LSEC
Ex vivo isolated LSEC were cultured in the presence of tumor necrosis factor (TNF)-α (10 ng/
ml; ImmunoTools, Friesoythe, Germany) and IFN-γ (20 ng/ml; R&D Systems, Wiesbaden,
Germany) for 24 h. Adhered cells were detached by accutase treatment (Sigma-Aldrich).
Transfection of LSEC
The expression vector Clathrin-LCa-EYFP (Addgene plasmid 21741) was provided by Chen
Chen (Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA)
[21]; CAV1-mEGFP (Addgene plasmid 27704) by Arnold Hayer (ETH Zurich, Institute of Bio-
chemistry, Zurich, Switzerland) [22]. Ex vivo isolated LSEC (1x106) were re-suspended in
100 μl electroporation buffer (90 mM phosphate buffer, pH 7.2, 10 mMMgCl2, 50 mM glu-
cose) before 4 μg plasmid DNA was added. Using an electroporation cuvette (2 mm gap;
Lonza, Cologne, Germany) in the ELPorator 1000 device [23], LSEC were subjected to continu-
ously combined high voltage (400 V/400 μs) and low voltage (150 V/20 ms) pulses. Immediate-
ly after pulse application, LSEC were transferred into pre-warmed Dulbecco's Modified Eagle
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Medium (Life Technologies, Carlsbad, CA) containing 10% fetal calf serum and were incubated
at 37°C for 48 h.
Real-time quantitative RT-PCR analysis
Total RNA was isolated from liver samples or LSEC by single-phase organic extraction (RNA-
Pure; Peqlab, Erlangen, Germany) and 100 ng RNA was reversely transcribed into cDNA using
the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Darmstadt, Ger-
many). Quantitative PCR was performed using a TaqMan Universal Master Kit and exon-
spanning, gene-specific assays (CXCL9, Mm00434946_m1; CXCL10, Mm00445235_m1;
CXCL12, Mm00445553_m1; CXCR4, Mm01292123_m1; CXCR3, Mm00438259_m1;
GAPDH, Mm03302249_g1; Applied Biosystems, Darmstadt, Germany) in a StepOne Plus
real-time PCR system (Applied Biosystems). Specific chemokine and chemokine receptor
mRNA expression was quantified in relation to Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) as the housekeeping gene using the ΔΔCT method [24].
Transmigration assay
LSEC were cultured overnight on gelatine-coated transwell membranes with a 5 μm pore size
(Corning, Sigma-Aldrich) to form confluent cell layers [18]. LSEC were treated with the specif-
ic clathrin inhibitor CPZ (30 μM) [25], the caveolae-specific inhibitors nystatin (10 μM) or fili-
pin (15 μM) [26] or the CXCR4 antagonist AMD3100 (10 μM) [27] added to the lower
chamber of the transwell for 10 min (CPZ, nystatin, filipin) or 60 min (AMD3100). After wash-
ing, LSEC layers were pre-incubated with the chemokine (CXCL12, 50 nM; CXCL9, CXCL10,
both 100 nM; all R&D Systems) applied to the lower chamber of the transwell for 120 min.
After removal of the chemokine, 5x105 total CD4+ T cells were added to the upper chamber of
the transwell and were allowed to transmigrate across the LSEC layer for 90 min. Transmi-
grated cells from the lower chamber or from the input were mixed with Fluoresbrite beads
(Polysciences, Eppelheim, Germany), stained with anti-CD4 (GK1.5) and anti-CD45RB anti-
body (16A; both BD Biosciences) and analyzed by flow cytometry. Absolute cell numbers were
determined by gating on CD4+ for total or CD45RBlow CD4+ for effector/memory CD4+ T
cells in relation to defined numbers of beads.
Confocal laser scanning microscopy
LSEC were cultured overnight on transwell inserts. AlexaFluor 647-labeled CXCL12 and
CXCL10 (both 50 nM) or AlexaFluor 488-labeled acetylated-low density lipoprotein (AcLDL;
10 μg/ml; Life Technologies) were added to the lower chamber of the transwell for indicated
times. Subsequently, LSEC were fixed with 4% paraformaldehyde (Sigma-Aldrich) and stained
with mouse anti-clathrin (3F133), mouse anti-caveolin-1 (7C8; both Santa Cruz Biotechnology,
Santa Cruz, CA), rabbit anti-early endosome antigen (EEA)1 (C45B10; Cell Signaling Technol-
ogy, Danvers, MA), rabbit anti-green fluorescent protein (GFP), rabbit anti-transferrin recep-
tor (TfR) and rat anti-lysosomal-associated membrane protein (LAMP)-1 (1D4B; all Abcam,
Cambridge, UK) antibody followed by AlexaFluor 488-conjugated anti-mouse, AlexaFluor
647-labeled anti-rat, AlexaFluor 488-conjugated anti-rabbit or anti-rat (all Live Technologies,
Karlsruhe, Germany) secondary antibody. Negative controls were performed by omitting the
primary antibodies. Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI) (Roche,
Grenzach-Whylen, Germany). LSEC were treated with CPZ (30 μM), filipin (15 nM), nystatin
(10 nM) or AMD3100 (10 μM) added to the lower chamber for 10 min (CPZ, nystatin, filipin)
or 60 min (AMD3100). LSEC were washed, followed by chemokine incubation (60 min) as
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described above. Images were taken with an LSM 510 Meta confocal laser scanning microscope
(Carl Zeiss MicroImaging, Heidelberg, Germany).
Immunohistochemistry and immunofluorescence
To quantify T-cell infiltration, paraffin-embedded liver sections were stained with rabbit anti-
CD3 antibody (N1580; Dako, Hamburg, Germany) followed by anti-rabbit secondary antibody
(Dianova, Hamburg, Germany) and the Streptavidin-Alkaline Phosphatase Kit (Dako) using
Fast Red as chromogen. All CD3+ cells per high power field (hpf) and three hpf per liver sam-
ple were counted. For immunofluorescence, shock-frozen liver tissue was cut into 4 μm sec-
tions and stained with rat anti-CD146 antibody followed by AlexaFluor 488-labeled anti-rat
secondary antibody (Dianova). Subsequently, liver sections were stained with rabbit anti-
CXCL9 (Santa Cruz Biotechnology) followed by AlexaFluor 455-labeled anti-rabbit secondary
antibody (Dianova). Negative controls were performed by omitting the primary antibodies.
Images were taken with an AxioImager Z1 microscope and processed with Axiovision software
(Carl Zeiss MicroImaging).
Hepatitis induction and CPZ treatment
Concanavalin (Con) A (20 mg/kg; Sigma-Aldrich) was injected intravenously to induce T cell-
mediated hepatitis in C57BL/6 mice. CPZ (3 mg/kg) was intraperitoneally administered 60
min after Con A-treatment. Blood was drawn from individual mice to monitor progression of
hepatitis. Liver injury was quantified by automated measurement of plasma activities of alanin
transaminase (ALT) using a Roche modular analyzer.
In vivo homing assay
Mice received CPZ 7 h after Con A treatment. Radioactively labeled CD4+ T cells (1x106;
20 μCi 51Cr; GE Healthcare, Munich, Germany) were intravenously injected 120 min after ad-
ministration of CPZ. After 60 min migration time, the radioactivity of the liver and the remain-
ing body was counted using a Wizard gamma counter (Wallac, Turku, Finland). The
percentage of organ-specific radioactivity in relation to the total recovered radioactivity re-
flected the percentage of cells that have migrated into the respective organ [28].
Data analysis
Data were analyzed and statistical significance was determined using the GraphPad Prism soft-
ware (San Diego, CA). Statistical comparison was carried out using the nonparametric two-
tailed Mann-Whitney test.
Results
Hepatic expression of the inflammatory chemokines CXCL9 and
CXCL10 is strongly increased during T cell-mediated hepatitis
In situ production, transport and presentation of chemokines in the liver are crucial for the he-
patic recruitment of circulating T cells [10,29,30]. In order to identify chemokines induced in
the inflamed liver, we used the model of Con A-induced T cell-mediated hepatitis and analyzed
hepatic expression of inflammatory and homeostatic chemokines. The mRNA expression of
inflammatory CXCL9 and CXCL10 was significantly increased 3 h after induction of hepatitis
(Fig 1A), a time point well before liver damage became detectable by plasma ALT levels (Fig
1B). In contrast, the mRNA expression of the homeostatic chemokine CXCL12 was significant-
ly reduced at the same time point. CXCL9 and CXCL10 mRNA expression decreased over time
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whereas CXCL12 recovered to its initial levels within 24 h after hepatitis induction (Fig 1A). By
using immunofluorescence analysis, we detected CXCL9 in the inflamed liver tissue. It particu-
larly co-localized with CD146 demonstrating that CXCL9 was associated with LSEC lining the
liver sinusoids (Fig 1C).
LSEC express and internalize homeostatic and inflammatory
chemokines
Endothelial chemokine expression or internalization of chemokines produced by other liver
cells can account for the presence of chemokines in LSEC. We studied the expression of ho-
meostatic and inflammatory chemokines in LSEC by quantitative RT-PCR analysis. In resting
LSEC, we detected expression of CXCL12 mRNA but not of CXCL9 and CXCL10 mRNA. Es-
tablishing inflammatory conditions in vitro, LSEC were activated with TNF-α and IFN-γ. Acti-
vated LSEC markedly down-regulated CXCL12 whereas CXCL9 and CXCL10 expression was
strongly increased (Fig 2A).
To analyze chemokine uptake, we incubated LSEC with fluorochrome-labeled CXCL12 or
CXCL10 and determined the intracellular fluorescence intensity by flow cytometry (Fig 2B).
We showed a time-dependent internalization of both chemokines at 37°C that was absent at
4°C (Fig 2C) indicating that chemokine internalisation by LSEC was an active, energy-
dependent process. In addition, LSEC cultured on transwell membranes were incubated with
fluorochrom-labeled CXCL12 or CXCL10 present in the lower chamber of the transwell and
Fig 1. Hepatic chemokine expression during T cell-mediated hepatitis. Con A was intravenously injected into C57BL/6 mice. (A) Quantitative RT-PCR
analysis of CXCL9, CXCL10 and CXCL12 mRNA expression in liver tissue of healthy or Con A-treated mice was performed. The chemokine expression was
quantified in relation to GAPDH as a housekeeping gene. Mean values ± SD of 4–5 mice per group are shown. (B) Plasma ALT levels were determined at
indicated time points. Medians of three independent experiments with 4–5 mice per group are shown. (C) Liver samples were stained with anti-CD146 and
anti-CXCL9 antibody 12 h after hepatitis induction. Nuclei were stained with DAPI. Arrows indicate co-localization of CXCL9 and CD146. Bars represent
50 μm. Images are representative of three independent experiments. * p< 0.05; *** p< 0.001; ns, not significant.
doi:10.1371/journal.pone.0123867.g001
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we visualized basolateral internalization and localization of both chemokines in vesicle-like
structures in LSEC (Fig 2D).
In summary, LSEC expressed and internalized homeostatic as well as inflammatory
chemokines.
LSEC internalize CXCL12 via CXCR4-mediated endocytosis
Chemokines are bound by their corresponding receptors and we asked whether LSEC take up
chemokines by receptor-mediated endocytosis. Resting LSEC expressed CXCR4, the receptor
for CXCL12, which was strongly decreased after treatment with TNF-α and IFN-γ. In contrast,
levels of CXCR3 mRNA were very low in resting LSEC and not increased under inflammatory
conditions (Fig 3A). Blockage of CXCR4 by the specific antagonist AMD3100 inhibited
CXCL12 internalisation in LSEC (Fig 3B and 3C). We further analyzed whether inhibition of
basolateral CXCL12 uptake in LSEC affect CXCL12-dependent transmigration of CD4+ T cells
across LSEC. To avoid direct inhibitory effects of AMD3100 on CD4+ T cells, we sequentially
Fig 2. Chemokine expression and internalization by LSEC. (A) Chemokine mRNA expression was
quantified in resting and TNF-α/IFN-γ activated LSEC in relation to GAPDH. (B) LSEC layer were incubated
with fluorochrome-labeled CXCL10 or CXCL12 at 37°C or 4°C. Histograms show chemokine uptake
determined by flow cytometry. Filled graph, no chemokine at 37°C; thin line overlapping with filled graph,
chemokine incubation at 4°C; bold line, chemokine incubation at 37°C. (C) Diagram shows fold increase of
geometric mean fluorescence intensity (GMFI) of LSEC incubated with chemokine in relation to GMFI without
chemokine incubation at 37°C. Mean values ± SD of 4 independent experiments are shown. (D) LSEC were
incubated with fluorochrome-labeled CXCL10 or CXCL12 added to the lower chamber of the transwell for 30
min. Nuclei were stained with DAPI. Representative images of three independent experiments are shown.
Bars represent 10 μm. Mean values ± SD of 2–4 independent experiments are shown. ** p< 0.01.
doi:10.1371/journal.pone.0123867.g002
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pre-incubated LSEC layers with the CXCR4 inhibitor and CXCL12 applied to the lower cham-
ber of the transwell. After removal of unbound chemokine, transmigration assays with CD4+ T
cells were performed. Basolateral pre-incubation of LSEC with CXCL12 led to significantly in-
creased CD4+ T-cell transmigration and blockage of endothelial CXCR4 inhibited this process
(Fig 3D). Corresponding to the very low expression of CXCR3 by LSEC, neither internalisation
of CXCL10 by LSEC from CXCR3-deficient mice (Fig 3E) nor CXCL10-dependent transmigra-
tion of effector/memory CD4+ T cells across CXCR3-/- LSEC layer was affected compared to
wild type (WT) LSEC (Fig 3F).
These data demonstrate that LSEC internalized CXCL12 via CXCR4-mediated endocytosis
leading to enhanced CD4+ T-cell transmigration whereas CXCL10 facilitated transmigration
of effector/memory CD4+ T cells but its endothelial uptake was independent of the specific
receptor.
LSEC internalize chemokines in clathrin-coated vesicles
Clathrin-dependent endocytosis and caveolae are the two major pathways mediating internali-
zation and sorting of extracellular molecules [31]. To define the pathway by which LSEC inter-
nalize chemokines, LSEC were basolaterally incubated with CXCL12 and stained for clathrin
or caveolin-1. CXCL12 co-localized with clathrin but not with caveolin-1 (Fig 4A). To confirm
these findings, LSEC were transfected for the transient overexpression of tagged clathrin or
Fig 3. Receptor-mediated chemokine internalization by LSEC. (A) Expression of CXCR3 and CXCR4mRNA in resting and in vitro activated LSEC was
quantified in relation to GAPDH. (B) LSEC were treated with AMD3100 prior to incubation with fluorochrome-labeled CXCL12 for 60 min and analyzed by
flow cytometry. (C) LSEC were treated with AMD3100 present in the lower chamber of the transwell prior to incubation with AlexaFluor 647-labeled CXCL12
added to the lower chamber for 60 min. Nuclei were stained with DAPI. Representative images of three independent experiments are shown. Bars represent
20 μm. (D) LSEC were treated with AMD3100 present in the lower chamber of the transwell prior pre-incubation with CXCL12 added to the lower chamber for
120 min. After removal of unbound chemokine, transmigration assays with total CD4+ T cells were performed. (E) LSEC from CXCR3-/- mice were incubated
with fluorochrome-labeled CXCL10 for 120 min. (F) CXCR3-deficient LSEC were pre-incubated with CXCL10 present in the lower chamber of the transwell
for 120 min. Transmigration assays with effector/memory CD4+ T cells were performed. Mean values ± SD of 2–4 independent experiments are shown.
* p< 0.05; ** p< 0.01; ns, not significant.
doi:10.1371/journal.pone.0123867.g003
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caveolin-1 and stained with anti-GFP. We again showed co-localization of CXCL12 with cla-
thrin but not with caveolin-1 (Fig 4B).
LSEC were treated with the caveolae-specific inhibitors nystatin or filipin or with the specif-
ic clathrin inhibitor CPZ prior to basolateral chemokine incubation. Neither nystatin nor fili-
pin affected the uptake of CXCL12 or CXCL10 in LSEC. In contrast, CPZ-treated LSEC were
strongly impaired in their ability to internalize both chemokines (Fig 4C and 4D). In addition,
Fig 4. Interference of LSEC-mediated chemokine supply by clathrin and caveolae inhibitors. (A) LSEC were incubated with AlexaFluor 647-labeled
CXCL12 added to the lower chamber of the transwell for 10 min. LSEC were stained with anti-clathrin or anti-caveolin-1 antibody. Arrows indicate co-
localization. Representative images of 2–4 independent experiments are shown. (B) Clathrin-LCa-EYFP (clathrin) or CAV1-mEGFP (caveolin-1) transfected
LSEC were incubated with CXCL12-AlexaFluor 647 added to the lower chamber for 10 min. LSEC were stained with anti-GFP antibody. Nuclei were stained
with DAPI. Bars represent 5 μm. (C) LSEC were treated with nystatin, filipin or CPZ present in the lower chamber of the transwell prior to incubation with
CXCL12-AlexaFluor 647 added to the lower chamber for 60 min. Representative images of three independent experiments are shown. Bars represent
20 μm. (D, E) LSEC from (D) WT or (E) CXCR3-/- mice were treated with the indicated substances prior to incubation with fluorochrome-labeled CXCL12 or
CXCL10 for 60 min. Bar graphs show GMFI fold increase of LSEC incubated with chemokine compared to GMFI without chemokine incubation. (F, G) LSEC
layer from (F) WT or (G) CXCR3-/- mice were treated with the indicated substances present in the lower chamber of the transwell. After washing, LSEC were
incubated with the chemokines added to the lower chamber for 120 min. After removal of unbound chemokine, transmigration assays with total CD4+ T cells
(CXCL12) and effector/memory CD4+ T cells (CXCL10, CXCL9) were performed. Mean values ± SD from 2–4 individual experiments are shown. * p< 0.05;
ns, not significant.
doi:10.1371/journal.pone.0123867.g004
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the inhibitory effect of CPZ on endothelial chemokine internalization was also shown for
CXCL10 uptake in CXCR3-/- LSEC (Fig 4E). In line with these data, basolateral treatment of
LSEC layers with the caveolae-specific inhibitors prior to chemokine incubation did not alter
chemokine-dependent CD4+ T-cell transmigration. However, CPZ treatment significantly de-
creased CXCL9- and CXCL10-dependent transmigration of effector/memory CD4+ T cells as
well as CXCL12-triggered transmigration of CD4+ T cells across LSEC layer (Fig 4F). The
CXCL10-dependent transmigration of effector/memory CD4+ T cells across CXCR3-/- LSEC
layer was also strongly reduced after treatment with CPZ (Fig 4G).
In summary, the clathrin pathway proved crucial in LSEC-mediated chemokine transfer to
CD4+ T cells.
LSEC transfer internalized chemokines to early endosomes but not to
recycling endosomes or lysosomes
To further determine molecular mechanisms involved in endothelial chemokine transport, we
performed co-localization studies of chemokines and components of the endocytic pathway.
We identified early endosomes and recycling endosomes by staining with antibodies specific
for EEA1 [32] and TfR [33], respectively. Lysosomes were identified by staining for LAMP-1
[34]. LSEC were basolaterally incubated with CXCL12 or CXCL10 for indicated time points.
After 15 min, both chemokines showed co-localization with EEA1 that was strongly decreased
after 30 min (Fig 5A, Table 1). At this time point, neither CXCL10 nor CXCL12 co-localized
with TfR (Fig 5B, Table 2). After 60 min, CXCL10 and CXCL12 did not co-localize with
LAMP-1 and co-localization was also not found after 120 min of incubation (Fig 5C, Table 3).
Interestingly, basolaterally internalized AcLDL, a protein that usually ends up in the lyso-
some [35], also did not co-localize with LAMP-1 in LSEC after 60 min and 120 min of incuba-
tion (Fig 5D, Table 3). In addition, both chemokines showed a strong co-localization with
AcLDL after 60 min incubation time and also after incubation in medium for another hour
pointing to a shared intracellular transport pathway (Fig 5E, Table 4).
Recruitment of CD4+ T cells into the inflamed liver is decreased after
administration of CPZ
During liver inflammation, the rate of T-cell recruitment via the sinusoidal endothelium
strongly increases [36]. Having shown in vitro that CPZ affects endothelial chemokine transfer
leading to reduced transmigration of CD4+ T cells across LSEC layer we asked whether CPZ
also influences CD4+ T-cell recruitment to the inflamed liver.
To induce hepatic inflammation, mice were treated with Con A and received CPZ 7 h later,
a time point when hepatitis was established (see Fig 1B). Radioactively labeled CD4+ T cells
were transferred into the mice and their immigration into the liver was assessed by an in vivo
homing assay. In mice that received Con A, recruitment of CD4+ T cells to the inflamed livers
was significantly enhanced compared to livers of healthy mice. Strikingly, despite liver inflam-
mation, migration of CD4+ T cells into the liver was significantly reduced if mice received CPZ
in addition to Con A. CPZ itself did not influence hepatic migration of transferred CD4+ T
cells in healthy mice (Fig 6).
Accumulation of CXCR3+ CD4+ T cells in the inflamed liver is reduced
after administration of CPZ
During autoimmune hepatitis, activated T cells accumulate within the liver. We again used the
model of Con A-induced T cell-mediated hepatitis to study the effect of interfering with the
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Fig 5. Co-localization of CXCL12 and CXCL10 with components of the endocytic pathway. LSEC were incubated with AlexaFluor 647-labeled CXCL12
or CXCL10 present in the lower chamber of the transwell. LSEC were stained with (A) anti-EEA1, (B) anti-TfR or (C) anti-LAMP-1 antibody. (D) LSEC were
incubated with AlexaFluor 488-labeled AcLDL present in the lower chamber of the transwell and stained with anti-LAMP-1 antibody. (E) LSEC were
incubated with AlexaFluor 647-labeled chemokine and AcLDL-AlexaFluor 488 present in the lower chamber of the transwell. Representative images of two
independent experiments are shown. Bars represent 5 μm.
doi:10.1371/journal.pone.0123867.g005
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clathrin pathway on hepatic T-cell infiltration during liver inflammation. Mice were treated
with Con A and received CPZ 60 min after hepatitis induction, a time point when migration of
activated T cells to the liver has not yet taken place. One day after hepatitis induction, liver tis-
sue was stained with an anti-CD3 antibody to identify T cells. We showed a strong hepatic ac-
cumulation of CD3+ T cells around the portal areas during liver inflammation. This T-cell
accumulation was significantly decreased after administration of CPZ (Fig 7A). Arguing
against direct effects of CPZ on T-cell activation in vivo, we detected similar expression of the
early activation marker CD69 and the inflammatory cytokine IFN-γ in hepatic CD90.2+ total
T cells as well as CD4+ T cells of mice that received CPZ and Con A compared to those of only
Con A-treated mice (S1 Fig).
Table 1. Co-localization of CXCL10 and CXCL12 with EEA1 in LSEC.
Chemokine Time (min) Cell # # vesicles per cell Co-localization with EEA1 (%)
red yellow
CXCL10 15 91 10 (5; 15) 7 (3.5; 10) 75 (61.8; 88.6)
30 85 10 (6; 13) 4 (2; 6) 38.9 (21.1; 55.6)
CXCL12 15 106 8 (6; 13) 6 (4; 9) 75 (66.7; 87.5)
30 105 12 (7; 17) 5 (3; 8) 43.5 (28.6; 59.1)
LSEC were incubated with AlexaFluor 647-labeled chemokine (red) present in the lower chamber of the transwell for 15 min or 30 min. Cells were stained
with anti-EEA1 antibody (green). Red and yellow vesicles were counted per cell and co-localization was calculated as % of yellow vesicles within red
ones. Medians (1. quartile; 3. quartile) of two independent experiments are given.
doi:10.1371/journal.pone.0123867.t001
Table 2. Co-localization of CXCL10 and CXCL12 with TfR in LSEC.
Chemokine Time (min) Cell # # vesicles per cell Co-localization with TfR (%)
red yellow
CXCL10 30 97 11 (7; 15) 0 (0; 1) 0 (0; 9.5)
CXCL12 30 102 10 (7.5; 15) 0 (0; 1) 0 (0; 10)
LSEC were incubated with AlexaFluor 647-labeled chemokine (red) present in the lower chamber of the transwell for 30 min. Cells were stained with anti-
TfR antibody (green). Medians (1. quartile; 3. quartile) of two independent experiments are given.
doi:10.1371/journal.pone.0123867.t002
Table 3. Co-localization of CXCL10, CXCL12 and AcLDL with LAMP-1 in LSEC.
Reagent Time (min) Cell # # vesicles per cell Co-localization with LAMP-1 (%)
red/green yellow
CXCL10 60 96 12 (7.8; 18) 0 (0; 1) 0 (0; 6.4)
120 73 10 (6; 20) 0 (0; 1) 0 (0; 6.3)
CXCL12 60 97 13 (7; 17) 0 (0; 1) 0 (0; 5.9)
120 79 14 (9; 20) 0 (0; 1) 0 (0; 6.9)
AcLDL 60 37 18 (11; 24) 0 (0; 1) 0 (0; 3.3)
120 28 16.5 (10; 20) 0 (0; 1) 0 (0; 5.9)
LSEC were incubated with an AlexaFluor 647-labeled chemokine (red) or AlexaFluor 488-labeled AcLDL (green) present in the lower chamber of the
transwell for 60 min or 120 min. Cells were stained with anti-LAMP-1 antibody (green in combination with CXCL10 or CXCL12; red in combination with
AcLDL). Medians (1. quartile; 3. quartile) of two independent experiments are given.
doi:10.1371/journal.pone.0123867.t003
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We also tested the effect of CPZ on chemokine-dependent T-cell infiltration during liver in-
flammation. We quantified the fraction of hepatic CD4+ T cells expressing CXCR3, the recep-
tor for CXCL9 and CXCL10 that were strongly up-regulated at an early stage of Con A-
induced hepatitis (see Fig 1A). The percentage of CXCR3+ CD4+ T cells significantly increased
in the inflamed livers of Con A-treated mice compared to those of healthy mice. Interestingly,
in mice that received CPZ the percentage of hepatic CXCR3+ CD4+ T cells was significantly re-
duced (Fig 7B) further supporting the finding that inflammation-induced T-cell migration to
the liver is diminished after administration of a clathrin inhibitor in vivo.
Discussion
T-cell migration into the liver tissue is a major factor determining the pathogenesis of hepatic
inflammation. Hepatic expression of CXCR3 ligands is strongly induced in many inflammato-
ry liver diseases [10–12,37] and infiltrating effector T cells express high levels of CXCR3
Table 4. Co-localization of CXCL10 and CXCL12 with AcLDL in LSEC.
Chemokine Time (min) Cell # # vesicles per cell Co-localization with AcLDL (%)
red yellow
CXCL10 60 87 8 (5.5; 12.5) 7 (5; 11.5) 90.9 (81.7; 100)
60 + 60 94 10 (7; 14) 10 (6.3; 13.8) 100 (91.1; 100)
CXCL12 60 81 7 (5; 11) 7 (5; 10) 100 (92.9; 100)
60 + 60 83 9 (6; 12) 8 (5.5; 11) 100 (88.9; 100)
LSEC were incubated with AlexaFluor 647-labeled chemokine (red) and AlexaFluor 488-labeled AcLDL (green) present in the lower chamber of the
transwell for 60 min or for additional 60 min after removal of chemokine and AcLDL. Medians (1. quartile; 3. quartile) of two independent experiments
are given.
doi:10.1371/journal.pone.0123867.t004
Fig 6. Migration of CD4+ T cells into the inflamed and healthy liver after administration of CPZ.C57BL/
6 mice were treated with Con A and received CPZ 7 h after hepatitis induction. Healthy mice also received
CPZ. Radioactively labeled total CD4+ T cells were intravenously transferred into mice 120 min after
administration of CPZ. Liver-specific radioactivity in relation to total radioactivity of the body was determined
after 60 min migration time. Mean values ± SD of 4 independent experiments with three mice per group are
shown. ** p< 0.01; *** p< 0.001; ns, not significant.
doi:10.1371/journal.pone.0123867.g006
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[38–41]. During liver inflammation, CXCR3 ligands have been shown to be expressed by vari-
ous liver resident cells inclusive LSEC, hepatocytes, stellate cells, and cholangiocytes
[30,42–45]. In Con A-induced hepatitis, we found CXCL9 in the inflamed liver to be closely as-
sociated with LSEC, which represent the first contact site for T-cell immigration into the liver.
Under inflammatory conditions in vitro, LSEC expressed CXCL9 and CXCL10 further empha-
sizing the finding that LSEC contribute to the reservoir of chemokines that are expressed dur-
ing liver inflammation.
Beside chemokine expression LSEC were able to actively internalize basolateral chemokines
which may be secreted by other cell types of the subadjacent liver tissue. Perivascularly express-
ed chemokines can be transported across the endothelium [42,46–50] and immobilized on the
endothelial glycocalyx [42,51,52] to support localized lymphocyte recruitment. We have previ-
ously shown that LSEC transfer basolaterally internalized chemokines to CD4+ T cells thereby
enhancing T-cell transmigration [18]. What structures are involved in the endothelial traffick-
ing of chemokines? Chemokine receptors mainly regulate leukocyte migration but have also
been identified on endothelia [53]. The functional outcome of CXCR4 expression differs be-
tween endothelial cells and T cells. CXCR4+ T cells do not efficiently take up CXCL12 but are
highly motile in response to this chemokine whereas tissue-anchored CXCR4+ bone marrow
endothelial cells regulate CXCL12 availability by transcytosis [47]. Correspondingly, we here
demonstrated that the blockage of LSEC-expressed CXCR4 inhibited CXCL12 internalization
and CXCL12-dependent CD4+ T-cell transmigration strongly indicating a role of this chemo-
kine receptor in LSEC-mediated chemokine transport to CD4+ T cells. In homeostasis,
CXCL12 was constitutively expressed in liver tissue and we assumed that the LSEC-mediated
transfer of CXCL12 from the tissue to the blood-endothelial interface is involved in T-cell mi-
gration as part of the hepatic immune surveillance. In acute T cell-induced hepatitis, CXCL12
Fig 7. Hepatic accumulation of CXCR3+ CD4+ T cells during T cell-mediated hepatitis after administration of CPZ.Mice were treated with Con A and
received CPZ 60 min after hepatitis induction. (A) Liver samples were stained with anti-CD3 antibody 24 h after hepatitis induction. Portal CD3+ T-cell
numbers were counted per hpf. Arrows indicate T cells. Representative images and medians of two independent experiments with 5 mice per group. Bars
represent 50 μm. (B) NPC were isolated 24 h after hepatitis induction, stained with anti-CD4 and anti-CXCR3 antibody and analyzed by flow cytometry.
Representative dot plots and medians of two independent experiments with 3–4 mice per group. * p< 0.05; ** p< 0.01; *** p< 0.001.
doi:10.1371/journal.pone.0123867.g007
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expression was markedly down-regulated suggesting that this chemokine did not mediate he-
patic T-cell recruitment during Con A-induced liver inflammation. However, CXCL12-trig-
gered infiltration of CXCR4+ lymphocytes has been described during hepatitis C and B virus
infection [54] thus, CXCR4-dependent endothelial CXCL12 transport may also play a role in
the pathogenesis of chronic liver infections.
In contrast to endothelial CXCL12 internalization which strictly depended on CXCR4, LSEC
did not express CXCR3 and CXCL10 was internalized independently of its receptor. Another
study reported expression of CXCR3 by dermal and lung microvessel endothelium but also in
this case the uptake of CXCL10 was not receptor dependent [50]. Together with the fact that
CXCR3 expression in LSEC was also not induced under inflammatory conditions, where endo-
thelial transport of inflammatory chemokines may be of particular importance, our data empha-
size the assumption that mechanisms relating to CXCL9/10-induced signal transduction in
leukocytes are different from those used for endothelial trafficking. CXCR4 mediates both
CXCL12-triggered signal transduction in motile leukocytes as well as transport of CXCL12
across an endothelium. In contrast, the main function of CXCR3 seems to be signal transduction
in leukocytes in order to induce their recruitment to sites of inflammation whereas endothelial
transport of its ligands is mediated by other, so far not identified molecular mechanisms. The
non-signaling chemokine receptor Duffy antigen receptor is expressed on endothelial cells and
erythrocytes and binds chemokines of the CC and CXC family but not CXCL12. It has been
shown that the functional outcome of chemokine binding by Duffy antigen receptor for chemo-
kines is transcytosis [55,56] and it would be conceivable that this interceptor is involved in the
transport of the CXCR3 ligands across LSEC. Another study also described a receptor-indepen-
dent mechanism by which glycosaminoglycans mediated endothelial transcytosis of inflamma-
tory chemokines [57]. In our model of acute T cell-mediated hepatitis, fast up-regulation of
CXCL9 and CXCL10 in the liver tissue preceded parenchymal accumulation of effector T cells.
It is conceivable that enhanced local production and LSEC-mediated transport and presentation
of the CXCR3 ligands supported hepatic recruitment of CXCR3+ effector CD4+ T cells trigger-
ing inflammation as well as CXCR3+ regulatory CD4+ T cells necessary to suppress hepatitis
[58] and the balance of the cells recruited will determine the outcome of the liver disease.
Chemokine receptors undergo ligand-induced internalization through clathrin-mediated
endocytosis [47,59,60]. CPZ causes disruption of clathrin-coated vesicles [25]. Focussing on
this aspect of CPZ action, treatment of LSEC with CPZ inhibited internalization of both
CXCL12 and CXCL10 and significantly decreased chemokine-dependent transmigration of
CD4+ T cells across the LSEC layer. The clathrin-dependent internalization and presentation
of CXCL9 and CXCL10 in CXCR3-/- LSEC further support the assumption that a so far not
identified receptor is involved in the transport of the CXCR3 ligands across endothelial cells.
Several intracellular pathways regulate the fate of proteins after their internalization. Co-lo-
calization studies in LSEC showed that internalized chemokines were transferred to clathrin-
coated vesicles but not to caveolae. Corresponding to this finding, inhibition of caveolae in
LSEC neither affected chemokine internalization nor chemokine-dependent CD4+ T-cell
transmigration. Endothelial chemokine transport has been described to be mediated by either
caveolae or clathrin-coated vesicles dependent on the type of endothelium [47,49]. We exclud-
ed caveolae and demonstrated that LSEC used the clathrin pathway for chemokine transport.
We also showed that CXCL12 and CXCL10 were transferred to EEA1+ early endosomes short-
ly after internalization, an endocytic compartment downstream of the clathrin-mediated up-
take. Both chemokines left the early endosomes again but neither co-localized with LAMP-1
nor with TfR suggesting that LSEC did not primarily transfer basolaterally internalized chemo-
kines to the lysosomes for degradation or to the recycling endosomes to return them back to
the basolateral plasma membrane. Moreover, AcLDL, a protein that is internalized via
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scavenger receptors and usually degraded after internalization, was also not transferred to the
lysosomes and co-localized with the chemokines in LSEC. On the basis of these data, we as-
sume that the liver sinusoidal endothelium mainly transported perivascularly produced pro-
teins like chemokines to the blood-endothelial interface. The striking co-localization of
chemokines and AcLDL in LSEC suggests that scavenger receptors might be involved in endo-
thelial chemokine supply. We found no evidence that the type of chemokine to be transported
through the endothelial cell layer is selected. Thus, the pattern of chemokines presented by
LSEC seems to depend on the chemokine pool produced by liver resident cells which differs
under homeostatic and inflammatory conditions.
Having demonstrated that inhibition of the clathrin pathway by CPZ reduced the chemo-
kine-dependent transmigration of CD4+ T cells in vitro we also analyzed whether CPZ affects
T-cell migration into the liver in vivo. We showed that the strongly increased recruitment of
transferred CD4+ T cells into the inflamed liver of Con A-treated mice was abolished after ad-
ministration of CPZ during hepatitis whereas the clathrin inhibitor did not influence CD4+ T-
cell migration to the healthy liver. Moreover, the high frequency of CXCR3+ CD4+ T cells in
the inflamed liver tissue was strongly reduced after administration of CPZ. We excluded inhibi-
tory effects of CPZ on T-cell activation in vivo and another study also showed that CPZ did not
affect inflammatory cytokine production [61] during Con A-induced hepatitis which could be
possible reasons for the reduced hepatic infiltration of effector CD4+ T cells. These data dem-
onstrate that the inflammation-induced hepatic recruitment of T cells was especially impaired
after treatment with the clathrin inhibitor. CPZ might affect local chemokine production and/
or endothelial chemokine transport and presentation thereby attenuating effector T-cell migra-
tion into the inflamed liver. Despite potential other effects of CPZ on lymphocyte function, our
in vitro data suggested CPZ as a suitable model substance for this first study on the impact of
clathrin inhibition on the course of liver inflammation.
In summary, the data presented here indicate that the liver sinusoidal endothelium, which
acts as an anatomical barrier between the liver parenchyma and the blood circulation, contains
an intracellular transport system for the transfer of tissue-expressed chemokines across this
barrier in order to induce local recruitment of circulating T cells. We identified CXCR4- and
clathrin-dependent intracellular transport mechanisms involved in LSEC-mediated chemokine
transport to CD4+ T cells and demonstrated that inhibition of these processes diminished che-
mokine-dependent CD4+ T-cell transmigration in vitro. Our data showing that the inflamma-
tion-induced recruitment of effector CD4+ T cells into the inflamed liver can be modified by
treatment with a clathrin inhibitor led us to the assumption that endothelial chemokine supply
by transcytosis or production plays an important role in the regulation of local inflammation.
In this light, it is tempting to speculate that interventions in these processes during liver inflam-
mation could be a target for inhibition of lymphocyte infiltration thereby
counteracting immunopathology.
Supporting Information
S1 Fig. Hepatic T-cell activation after administration of CPZ.Mice were treated with Con A
and received CPZ 60 min after hepatitis induction. NPC isolated 6 h after Con A treatment
and stained for CD4, CD90.2, CD69 and IFN-γ were assessed by flow cytometry. (A) GMFI of
CD69 was determined on gated CD90.2+ or CD4+ T cells. (B) Percentages of CD90.2+ and
CD4+ T cells expressing IFN-γ were detected. Representative plots and mean values ± SD of
2–4 independent experiments with three mice per group are shown.  p< 0.05; ns,
not significant.
(TIF)
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